Literature DB >> 18070854

Cilostazol, a cAMP phosphodiesterase 3 inhibitor, in the treatment of poststroke depression.

Katsuji Nishimura, Jun Ishigooka, Yukiko Imamura, Shunichi Ihara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070854     DOI: 10.1176/jnp.2007.19.4.471

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


× No keyword cloud information.
  5 in total

1.  Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke.

Authors:  Yu Ri Kim; Ha Neui Kim; Ki Whan Hong; Hwa Kyoung Shin; Byung Tae Choi
Journal:  Psychopharmacology (Berl)       Date:  2015-12-21       Impact factor: 4.530

2.  Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway.

Authors:  Mona Khalifa; Rania M Abdelsalam; Marwa M Safar; Hala F Zaki
Journal:  Inflammopharmacology       Date:  2022-06-21       Impact factor: 5.093

3.  Evaluation of antidepressant and anxiolytic activity of phosphodiesterase 3 inhibitor - cilostazol.

Authors:  Dipesh S Patel; Indermeet Singh Anand; Parloop A Bhatt
Journal:  Indian J Psychol Med       Date:  2012-04

4.  Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke.

Authors:  Yu Ri Kim; Ha Neui Kim; Ki Whan Hong; Hwa Kyoung Shin; Byung Tae Choi
Journal:  Int J Mol Sci       Date:  2017-02-08       Impact factor: 5.923

5.  Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder.

Authors:  Mahmoud S Abdallah; Ahmed N Ramadan; Hend Omara-Reda; Noha O Mansour; Mohamed A Elsokary; Hozaifa K Elsawah; Shimaa Abdelsattar Zaki; Hend E Abo Mansour; Esraa M Mosalam
Journal:  CNS Neurosci Ther       Date:  2021-09-21       Impact factor: 5.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.